Literature DB >> 19759474

Seroprevalence of antibodies against Chlamydia trachomatis inclusion membrane proteins B and C in infected symptomatic women.

Rishein Gupta1, Sudha Salhan, Aruna Mittal.   

Abstract

BACKGROUND: Proteins in the inclusion membrane of Chlamydia trachomatis (CT) have been anticipated to play pivotal roles in the molecular and cellular interactions between the pathogen and host. However, there is lack of data on host immunity with respect to antibody responses against chlamydial inclusion proteins.
METHODOLOGY: We used full-length fusion proteins for CT inclusion membrane proteins B and C (IncB and IncC respectively), two early-infection phase proteins, to study their role in antibody generation during human infection.
RESULTS: Three hundred and fifty-five women (aged 22-36 years) attending the Gynaecology outpatient department, Safdarjang Hospital, New Delhi, India were enrolled in this hospital ethical committee approved study. Out of these, 108 were diagnosed to be cervical CT-positive. Of these 108 patients, 67 (62.03%) showed ELISA positivity for IncB IgG, and 64 (59.25%) for IncC IgG. There was a positive correlation between antibody titres against IncB and IncC and with antibodies against CT major outer membrane protein (MOMP) in CT-positive sera. Our data also showed a positive association between antibody titres against IncB and IncC in patients with cervicitis and pelvic inflammatory disease (PID). Significantly high antibody titres were detected in cervicitis cases compared with PID. There were significantly higher levels of serum cytokines (TNF-alpha, IFN-gamma and IL-12) in Inc-positive cervicitis cases than in PID cases. In addition, our study also showed higher IncB and IncC IgG(2) titres in comparison to respective IgG1, IgG3 and IgG4 titres in CT-positive sera.
CONCLUSION: Our data suggested that antibodies against CT IncB and IncC were prevalent in CT-positive women diagnosed with cervicitis or PID.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19759474     DOI: 10.3855/jidc.35

Source DB:  PubMed          Journal:  J Infect Dev Ctries        ISSN: 1972-2680            Impact factor:   0.968


  5 in total

Review 1.  Immunity and vaccines against sexually transmitted Chlamydia trachomatis infection.

Authors:  Sarah E M Howie; Patrick J Horner; Andrew W Horne; Gary Entrican
Journal:  Curr Opin Infect Dis       Date:  2011-02       Impact factor: 4.915

Review 2.  Burden of Chlamydia trachomatis in India: a systematic literature review.

Authors:  Pierre Thomas; Joke Spaargaren; Rajiv Kant; Rubina Lawrence; Arvind Dayal; Jonathan A Lal; Servaas A Morré
Journal:  Pathog Dis       Date:  2017-07-31       Impact factor: 3.166

3.  An Integrated Care Model With Implementation Roadmap to Improve Chlamydia trachomatis Management and Control in India.

Authors:  Pierre P M Thomas; Ramesh R Allam; Elena Ambrosino; Jelena Malogajski; Jonathan A Lal; Servaas A Morré; Remco P H Peters
Journal:  Front Public Health       Date:  2018-11-09

4.  Modulation of cytokines and transcription factors (T-Bet and GATA3) in CD4 enriched cervical cells of Chlamydia trachomatis infected fertile and infertile women upon stimulation with chlamydial inclusion membrane proteins B and C.

Authors:  Rishein Gupta; Harsh Vardhan; Pragya Srivastava; Sudha Salhan; Aruna Mittal
Journal:  Reprod Biol Endocrinol       Date:  2009-08-22       Impact factor: 5.211

5.  Host immune responses to chlamydial inclusion membrane proteins B and C in Chlamydia trachomatis infected women with or without fertility disorders.

Authors:  Rishein Gupta; Pragya Srivastava; Harsh Vardhan; Sudha Salhan; Aruna Mittal
Journal:  Reprod Biol Endocrinol       Date:  2009-04-28       Impact factor: 5.211

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.